Correction to “Nanoparticle-Mediated Cuproptosis and Photodynamic Synergistic Strategy: A Novel Horizon for Cancer Therapy”

IF 2.9 2区医学 Q2 ONCOLOGY

Cancer Medicine Pub Date : 2025-07-23 DOI:10.1002/cam4.71022

引用次数: 0

Abstract

Zhang, J., Zhang, A., Guo, Y., Miao, G., Liang, S., Wang, J. and Wang, J. (2025), Nanoparticle-Mediated Cuproptosis and Photodynamic Synergistic Strategy: A Novel Horizon for Cancer Therapy. Cancer Med, 14: e70599. https://doi.org/10.1002/cam4.70599.

In the corresponding author section, the positions of the two corresponding authors are reversed. Wang Junhong is designated as the first corresponding author, while Wang Jie is listed as the second corresponding author. This article is free from any conflicts of interest, and all co-authors have consented to the modification of the corresponding author sequence.

We apologize for this error.

查看原文本刊更多论文

修正“纳米粒子介导的铜化和光动力协同策略：癌症治疗的新视野”

张军，张爱安，郭勇，苗刚，梁生，王军，王军，王军（2025），纳米粒子介导的Cuproptosis和光动力协同策略：癌症治疗的新视野。中华癌症杂志，14:771 - 779。https://doi.org/10.1002/cam4.70599.In通讯作者部分，两位通讯作者的位置是颠倒的。指定王俊红为第一通讯作者，王杰为第二通讯作者。本文不存在任何利益冲突，所有合作作者都同意对通讯作者序列进行修改。我们为这个错误道歉。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer Medicine ONCOLOGY-

CiteScore

5.50

自引率

2.50%

发文量

907

审稿时长

19 weeks

期刊介绍： Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas: Clinical Cancer Research Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations Cancer Biology: Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery. Cancer Prevention: Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach. Bioinformatics: Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers. Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.